Hims & Hers hit with growing number of investor lawsuits after Novo deal exit

An abrupt end to a short-lived partnership between Hims & Hers Health (NYSE:HIMS) and weight loss drugmaker Novo Nordisk (NVO) has led to a growing number of investor lawsuits against the telehealth company.

A lawsuit was filed by a group